StonvexLoading…
StonvexStonvexStonvexCore line items from CFG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-16 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.27B | $415.00M | $1.64B | $1.20B | $750.00M |
Operating Income | Not available | $650.00M | $2.33B | $1.65B | $1.02B |
Net Income | Not available | $517.00M | $1.83B | $1.30B | $809.00M |
EPS (Diluted) | $1.25 | $1.13 | $3.86 | $2.74 | $1.69 |
Total Assets | Not available | $227.92B | $226.35B | $222.75B | $218.31B |
Total Liabilities | Not available | $201.75B | $200.03B | $196.92B | $193.08B |
Cash & Equivalents | Not available | $12.33B | $12.73B | $11.65B | $8.55B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 426.02M | 429.24M | 431.45M | 432.77M |